Friday, 10 May 2013

Switzerland Pharmaceuticals and Healthcare Report Q2 2013

Business Monitor International Market Research Reports
Market Reports Online XML Feed
Switzerland Pharmaceuticals and Healthcare Report Q2 2013
May 8th 2013, 00:00

BMI View: While the patent cliff and the consequent availability of generic drugs, as well as price cuts ongeneric medicines and their increasing affordability, will work towards increasing the consumption ofgeneric medicines in Switzerland, BMI believes the government needs to do more to alter patients'' attitudestowards these drugs as this is the main growth deterrent.Headline Expenditure Projections? Pharmaceuticals: CHF6.58bn (US$7.02bn) in 2012 to CHF6.44bn (US$6.27bn) in 2013; -2.1% declinein local currency terms.? Healthcare: CHF67.60bn (US$72.11bn) in 2012 to CHF69.71bn (US$67.89bn) in 2013; +3.1% growthin local currency terms....

Delicious Digg Evernote Facebook Google Bookmarks Google Plus LinkedIn StumbleUpon Tumblr Twitter
You are receiving this email because you subscribed to this feed at

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

No comments:

Post a Comment